Celulite no Local de Injeção do Agonista de GLP-1: Rara, Mas Relevante

Simões, PB; Mateus, S; Brazão, H; Salvado, C

http://hdl.handle.net/10400.17/4634

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Rev Port Diabetes 2022_23.pdf		144.91 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

We present a case of cellulitis complicating with abscess formation as a possible complication of treatment with injectable GLP-1 agonists on a sixty-one-year-old woman. Pus cultures showed isolation of Streptococcus anginosus and clindamycin was started as targeted therapy but absence of improvement prompted a consultation with the surgery department and a manual surgical debridement was performed. A second isolate of Eikenella corrodens, which is frequently resistant to clindamycin, was identified. We opted for a switch to ceftriaxone and after nineteen days, having achieved clinical improvement, plans were made for her to continue to change her wound dressing at her local health center and for a short-term revaluation at a surgery outpatient consultation. Caring for social needs and assuring continuity across multiple care levels can be fundamental in preventing adverse effects from self-injectable drugs.